Status and phase
Conditions
Treatments
About
The purpose of this study is to evaluate efficacy and safety of Irbesartan and Amlodipine combined therapy in patients with essential hypertension inadequately controlled on Irbesartan monotherapy
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
271 participants in 3 patient groups
Loading...
Central trial contact
SeJin Kim
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal